FCMI
Foresite Capital Management IV Portfolio holdings
AUM
$124M
1-Year Return
24.36%
This Quarter Return
+43.81%
1 Year Return
-24.36%
3 Year Return
+1.86%
5 Year Return
+16.17%
10 Year Return
–
AUM
$232M
AUM Growth
-$73.8M
(-24%)
Cap. Flow
-$136M
Cap. Flow
% of AUM
-58.85%
Top 10 Holdings %
Top 10 Hldgs %
92.15%
Holding
19
New
2
Increased
5
Reduced
5
Closed
5
Top Buys
1 |
Arbutus Biopharma
ABUS
|
+$10.3M |
2 |
Cytokinetics
CYTK
|
+$5.3M |
3 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
+$2.43M |
4 |
SI-BONE Inc
SIBN
|
+$2.21M |
5 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$1.62M |
Top Sells
1 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
+$68.7M |
2 |
Ascendis Pharma
ASND
|
+$24.5M |
3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$17.8M |
4 |
OPTN
OptiNose
OPTN
|
+$12.6M |
5 |
Alector
ALEC
|
+$10M |
Sector Composition
1 | Healthcare | 69.56% |